Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
Top Cited Papers
Open Access
- 1 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 51 (5) , 496-505
- https://doi.org/10.1086/655681
Abstract
Background. The efficacy of tenofovir disoproxil fumarate (TDF) as part of combination antiretroviral treatment (ART) has been demonstrated in severaKeywords
This publication has 22 references indexed in Scilit:
- Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trialThe Lancet, 2009
- Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic StudyClinical Infectious Diseases, 2009
- Progressive Renal Tubular Dysfunction Associated with Long-Term Use of Tenofovir DFAIDS Research and Human Retroviruses, 2009
- Tenofovir renal toxicity targets mitochondria of renal proximal tubulesLaboratory Investigation, 2009
- Tenofovir-Associated Nephrotoxicity in Two HIV-Infected Adolescent MalesAIDS Patient Care and STDs, 2009
- Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational studyJournal of Antimicrobial Chemotherapy, 2008
- European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV‐infected adultsHIV Medicine, 2008
- Biological Effects of Short-Term or Prolonged Administration of 9-[2-(Phosphonomethoxy)Propyl]Adenine (Tenofovir) to Newborn and Infant Rhesus MacaquesAntimicrobial Agents and Chemotherapy, 2004
- How should meta‐regression analyses be undertaken and interpreted?Statistics in Medicine, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002